AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nour-Eldin, N.-E. A.
Right arrow Articles by Vogl, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nour-Eldin, N.-E. A.
Right arrow Articles by Vogl, T. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.08.1457
AJR 2009; 193:W43-W48
© American Roentgen Ray Society


Original Research

Risk Factors Involved in the Development of Pneumothorax During Radiofrequency Ablation of Lung Neoplasms

Nour-Eldin A. Nour-Eldin1, Nagy N. N. Naguib1, Ahmed-Sami Saeed2, Hanns Ackermann1, Thomas Lehnert1, Huedayi Korkusuz1 and Thomas J. Vogl1

1 Institute for Diagnostic and Interventional Radiology, Johann Wolfgang Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt am Main, Hessen 60590, Germany.
2 Department of Diagnostic and Interventional Radiology, Cairo University Hospital, Cairo, Egypt.

Received June 28, 2008; accepted after revision December 31, 2008.

 
N.-E. A. Nour-Eldin and N. N. N. Naguib contributed equally to the research work.

Address correspondence to N.-E. A. Nour-Eldin (nour410{at}hotmail.com).

WEB This is a Web exclusive article.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The purpose of this study was to retrospectively evaluate the risk factors involved in the development of pneumothorax during radiofrequency ablation of lung tumors.

MATERIALS AND METHODS. This retrospective study covered 124 ablation sessions for lung tumors (10 primary lesions, 114 metastatic lesions) in 82 patients (46 men, 36 women; mean age, 64.0 years) treated between December 2005 and January 2008. The exclusion criteria for ablation therapy were lesions with a maximal diameter greater than 5 cm and the presence of more than five lesions. A bipolar electrode needle was used under CT guidance. Four patients were treated with two ablation electrodes simultaneously.

RESULTS. The incidence of pneumothorax (detected with CT) was 11.3% (14 of 124 sessions). Pneumothorax was graded mild (lung surface retraction, ≤ 2 cm), moderate (lung surface retraction, 2-4 cm), or severe (lung surface retraction, ≥ 4 cm). Significant risk factors encountered in the development of pneumothorax were age greater than 60 years (p = 0.046), emphysema (p = 0.02), tumor diameter ≤ 1.5 cm (p = 0.0008), lesions in lower part of lung, (p = 0.027), aerated lung parenchyma traversed by the needle track for a distance ≥ 2.6 cm (p = 0.0017), and traversal of a major pulmonary fissure (p = 0.0004). Pneumothorax developed in one of the four patients in whom multiple electrodes were used. The mean depth of lung lesions complicated by pneumothorax was 2.9 ± 1.55 cm (range, 0-5.5 cm). Conservative treatment was performed in four of the 14 pneumothorax sessions (28.6%). In six of the 14 sessions (42.9%), immediate complete evacuation was achieved with an intercostal catheter and manual evacuation; chest tube placement was indicated in four sessions (28.6%). Two patients were treated with manual evacuation because evidence of a progressive increase in pneumothorax on the 24-hour follow-up CT scan indicated failure of conservative treatment.

CONCLUSION. The development of pneumothorax complicating radiofrequency ablation can be unpredictable, but the many risk factors involved can make the incidence higher among some patients than others. Some of these risk factors are technically avoidable and have to be ruled out.

Keywords: lung neoplasms • pneumothorax • radiofrequency ablation • risk factors


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Radiofrequency ablation of lung tumors represents a new era in the management of pulmonary neoplasms owing to the promising results of this procedure in local tumor control and its minimally invasive nature [1-12]. Despite the efficacy of radiofrequency ablation of lung neoplasms in local tumor control, the associated complications are limitations of the technique. Pneumothorax is the most frequent complication. Studies [2-11] have shown that the rate of pneumothorax varies between 9% and 52%. In the case of serious pneumothorax, chest tube placement is required, resulting in prolonged hospitalization and additional expenses. Adequate assessment of the risk factors that contribute to the development of pneumothorax is essential to the minimization of its incidence. The purpose of our study was to retrospectively evaluate the risk factors associated with the development of pneumothorax during radiofrequency ablation of pulmonary neoplasms.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Patient Sample
Institutional ethical committee review board approval was obtained. This retrospective study included 124 consecutive radiofrequency ablation sessions for lung neoplasms conducted between December 2005 and January 2008. Radiofrequency ablation was applied to 124 lung lesions (10 primary lesions, 114 metastatic lesions) in 82 patients (46 men, 36 woman; mean age, 64 ± 10.2 [SD] years; range, 37-82 years). The standard protocol for ablation therapy at our institution is to ablate only one lesion per session. Forty-three patients had one ablation session, 36 patients had two ablation sessions, and three patients had three ablation sessions. The interval between ablation sessions was 1-2 weeks. Tumors were pathologically proven and were classified as primary lung neoplasms in 10 patients (non-small cell lung cancer) and metastatic lung neoplasms in 72 patients (metastasizing from colorectal carcinoma in 42 patients, breast carcinoma in 15 patients, hepatocellular carcinoma in seven patients, renal cell carcinoma in three patients, prostatic carcinoma in one patient, and sarcoma in four patients). The exclusion criteria for ablation therapy were the presence of more than five lesions and lesions with an axial diameter greater than 5 cm.


Figure 1
View larger version (8K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 Chart shows study protocol for management of pneumothorax.

 
Assessment Before Ablation
The decision for radiofrequency ablation was made by the treating radiologist after consultation with the patient and the referring physician. Patient self-referrals were discussed in multi disciplinary meetings with members of the thoracic surgery, medical oncology, and pulmonary disease departments. Patients who refused surgery or were not considered candidates because of age, disease extent at the time of diagnosis, underlying lung disease, or other comorbid medical conditions were treated with radiofrequency ablation. A comprehensive clinical history was obtained; physical examination was performed; recent imaging studies were reviewed; and the indications, risks, and benefits of the procedure were discussed thoroughly. Written informed consent was obtained from all patients at the time of the procedure. Preprocedural laboratory investigations included a complete blood cell count and a coagulation profile that consisted of bleeding time, prothrombin time, prothrombin concentration, and international normalized ratio.

The patients were advised to stop taking anticoagulant and antiplatelet medications 2 days-1 week before the procedure. Prophylactic antibiotics were not routinely administered. Patients under went CT in the supine position immediately before treatment to confirm the number and size of tumors. The ablation parameters, including type, number and length of applicators, the position of the patient, and the site of puncture, were based on tumor size and anatomic location. The anatomic description of the location of lesions in the lung was divided into three zones: upper third, middle third, and basal third.

Radiofrequency Ablation
All lung radiofrequency ablation procedures were performed with CT fluoroscopic guidance and 5mm collimation (Somatom 4, Siemens Healthcare). Radiofrequency ablation was per formed under complete aseptic conditions by two interventional radiologists with 8 and 15 years of experience in radiofrequency ablation technique. Combination sedation and analgesia with fentanyl citrate (1 µg/kg body weight) and midazolam hydrochloride (0.010-0.035 mg/kg) were administered in a stepwise manner until the patient was drowsy. Sedation was administered by the same interventional radiologist for all procedures. Continuous ECG, pulse oximetry, and blood pressure monitoring was performed throughout the procedure.

Radiofrequency ablation was performed with a bipolar internally cooled applicator (ProSurge, Celon Medical Instruments) (electrode length, 20-40 mm; shaft diameter, 15 gauge [1.8 mm]; shaft length, 100-250 mm) and a system (Power System, Celon Medical Instruments) comprising a power control unit (Laboratory Power, Celon Medical Instruments) and triple peristaltic pump (Aquaflow, Celon Medical Instruments). The length of the needle electrode chosen was based on the distance between the skin surface and the lesion. Each lesion was ablated with one needle applicator, except in four cases in which two applicators were applied simultaneously to ablate the lesion. CT monitoring was used during ablation to observe the procedure, visualize potential complications, and administer prompt treatment when needed. Radiofrequency electrode track coagulation was routinely performed at the end of the procedure to prevent seeding of malignant cells in the needle track during removal of the needle electrode.

Complications, particularly pneumothorax, were assessed with CT during the ablation procedure and immediately after ablation. Regular clinical assessment of vital signs was performed for at least 8 hours before the patient was discharged and continued until the patient could be clinically discharged. Patients with pneumo thorax or pulmonary hemorrhage underwent clinical and CT follow-up 1 or 2 days before discharge.

Study Protocol for Pneumothorax Management
Pneumothorax that developed while the patient was on the CT scan table was graded mild (lung surface retraction of ≤ 2 cm), moderate (measured lung surface retraction, 2-4 cm), or severe (lung surface retraction, ≥ 4 cm) (Fig. 1).

Mild pneumothorax was a small accumulation of air accumulated in the pleural sac that did not increase with time and was not associated with mediastinal shift, respiratory distress, or circulatory disturbance. It was managed conservatively by close clinical observation of vital signs and monitoring for any manifestations of respiratory distress. CT of the chest was performed 1-6 hours after the development of pneumothorax. Discharge of the patient was permitted if serial chest radio graphs showed no progressive increase of pneumothorax.

Moderate pneumothorax necessitated immediate manual evacuation of air by application of an 8-gauge intercostal chest catheter connected to a triple-way valve system. With successful complete evacuation of air, treatment was the same as that of patients with mild stable pneumothorax. Failure of manual air evacuation or progressive respiratory distress necessitated insertion of an intercostal chest tube and water-seal drainage.

The manifestations of marked pneumothorax were respiratory or circulatory distress and a mediastinal shift or progressive pneumothorax that did not respond to manual evacuation. It was managed by insertion of an intercostal chest tube and water-seal drainage with overnight hospitalization and close monitoring of vital signs. Patient discharge was permitted after complete recovery.

Study Design and Statistical Analysis
Radiologic evaluation of preprocedural, intraprocedural, and postprocedural images was performed in consensus by two senior radiologists (8 and 15 years' experience). Clinical symptoms, side effects and complications, and imaging findings of pneumothorax were recorded. The sampling unit for analysis was number of sessions (n = 124 sessions). Each factor was compared between groups by use of univariate analysis. Groups were defined as patients with or without pneumothorax. The variables evaluated included patient factors such as age, sex, presence of pulmonary emphysema; tumor factors such as size, distance between the lesion and the pleural surface, and location (upper, middle, or lower zone); and ablation and technical factors such as length of aerated lung traversed by the electrode, use of multiple electrodes, and crossing a major pulmonary fissure in the ablation track. Depth of the lesion was defined as the shortest distance between the lesion and the parietal pleura measured on axial CT scans. This distance was not necessarily the same as the distance traversed by the needle track because the latter is affected by the accessibility of the lesion, the angulation needed for application of the electrode, and the subcostal or subscapular position of the lesion.

Univariate analyses were performed with the Mann-Whitney U test for numeric values and the Fisher's exact test for categoric values. A value of p < 0.05 was considered to indicate a statistically significant difference in all analyses. Risk related to needle gauge was alleviated by use of the same needle gauge in all cases. SPSS statistical software was used (version 8.0, SPSS).


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Fourteen of 124 sessions (11.3%) were complicated by pneumothorax. Statistical analysis of variable risk factors involved in the development of pneumothorax revealed that pneumothorax developed in patients with a mean age of 64.7 ± 8.5 years; range, 45-79 years) (Table 1, Fig. 2). The risk of pneumothorax was strongly correlated with age greater than 60 years (p = 0.046). In the pneumothorax group, 10 of the patients (71.4%) were men, and four (28.6%) were women (p = 0.16). Nine patients (64%) in whom pneumothorax developed had emphysema (Fisher's exact test, p = 0.02). Both age greater than 60 years and presence of emphysema were associated with pneumothorax (p = 0.02).


View this table:
[in this window]
[in a new window]

 
TABLE 1 : Relation Between Occurrence of Pneumothorax and Clinical Factors Evaluated With Univariate Analysis

 

Figure 2
View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 66-year-old man with metastatic lung lesion from colorectal carcinoma in apical segment of right upper lobe associated with emphysema as risk factor for pneumothorax during radiofrequency ablation. Axial CT scan immediately after radiofrequency ablation shows colorectal metastatic lesion (black arrow) surrounded by multiple emphysematous bullae (white arrowhead) complicated by pneumothorax (black arrowhead) with subcutaneous extension of air in anterior chest wall (white arrow).

 

The mean size of the lesions associated with pneumothorax was 1.91 ± 1.3 cm. The risk of pneumothorax correlated significantly with the size of the lesion; lesions smaller than 1.5 cm in diameter (mean, 1.02 ± 0.4 cm; range, 0.4-1.5 cm; p = 0.0008) were more likely to be associated with pneumothorax than were lesions larger than 1.5 cm (mean, 3.01 ± 0.4 cm; range, 1.6-5 cm; p = 0.055). Ablation of basal and middle lung zone lesions was associated with a 71.4% incidence of pneumothorax (10 sessions), in comparison with upper zonal lesion ablation, which was associated with a 28.6% incidence of pneumothorax (p = 0.027). Lesions complicated by pneumothorax were located a mean distance of 2.9 ± 1.55 cm (range, 0-5.5 cm) from the pleural surface, and this depth had a significant correlation with the incidence of pneumothorax (p = 0.03). The mean distance of lung traversed in the ablation track in sessions complicated by pneumothorax was 2.9 ± 1.55 cm (range, 0-5.5 cm). The occurrence of pneumothorax correlated with an increase in the distance of lung traversed in the ablation track from less than 2.5 cm (mean, 1.7 ± 0.8 cm; p = 0.37) to a more significant greater than 2.5 cm (mean, 4.1 ± 1.07 cm; range, 2.8-5.5 cm; p = 0.0017). Crossing a major pulmonary fissure in the ablation track was associated with pneumothorax, occurring in four sessions (28.6%) (p = 0.0004). One of four cases in which two electrodes were applied was complicated by pneumothorax.


Figure 3
View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 68-year-old man with pneumothorax associated with basal location of lesion. Chest CT scan shows metastatic deposit from hepatocellular carcinoma (arrow) in posterior basal aspect of left lower lung lobe complicated by pneumothorax (arrowhead) during ablation.

 
At repetition of ablation, pneumothorax developed in two cases. In eight cases (57.1%) pneumothorax was mild and nonprogressive and was managed conservatively. Delayed pneumothorax (after 24 hours) developed in one of these cases and was managed with intercostal chest tube drainage. In two cases (14.3%), pneumothorax was evacuated completely with an intercostal catheter and manual evacuation, and chest tube placement was indicated in four cases (28.6%). In one of the patients with a chest tube, a prolonged air leak developed and persisted for 6 days. The statistical relations between the variable risk factors and intercostal chest tube insertion are summarized in Table 2.


View this table:
[in this window]
[in a new window]

 
TABLE 2 : Relation Between Need for Chest Tube Placement and Clinical Factors Evaluated With Univariate Analysis

 

In 10 patients (71.4%), mild to moderate pneumothorax developed during ablation without interfering with electrode positioning or compromising the patient's clinical condition. Pneumothorax was managed conservatively for four patients and by manual evacuation for six patients without termination of the ablation session. In the cases of two of the four patients who had planned to undergo conservative treatment, evidence of progressive pneumothorax was found on the 24-hour CT scan. These patients were treated by manual evacuation.

For four patients (28.6%), the session was immediately terminated before completion of ablation therapy because marked and progressive pneumothorax compromised the clinical condition of the patient, did not respond to manual evacuation, and interfered with electrode positioning.


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The potential advantages of local tumor ablation therapy over surgical resection include selective damage, minimal treatment morbidity and mortality, less breathing impairment in patients with borderline lung function through sparing of healthy lung tissue, repeatability, fairly low cost, excellent imaging during the procedure and follow-up, and gain in quality of life with less pain and much shorter hospitalization because intervention is performed on an outpatient basis or with an overnight stay, leading to quicker resumption of social life [13]. Stereotactic radiation therapy is a noninvasive high-precision radiotherapy that has been used in the management of malignant disease of the lung with encouraging results. However, response evaluation after stereotactic radiation therapy can be difficult because fibrosis and subclinical radiation pneumonitis frequently occur, and establishing local control requires careful radiologic follow-up. Even the use of 18F-FDG PET is of limited value in differentiating fibrosis from tumor recurrence because treated volumes can show FDG uptake at least 12 months after treatment [14, 15].


Figure 4
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A 52-year-old woman with metastatic lung lesion from mammary carcinoma in apicoposterior segment of upper lobe of left lung. Axial CT scans show crossing of major pulmonary fissure as risk factor for pneumothorax during radiofrequency ablation. Axial CT scan shows presence of left oblique pulmonary fissure (arrowhead) between needle electrode (black arrow) and lesion (white arrow) before lung puncture.

 


Figure 5
View larger version (123K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B 52-year-old woman with metastatic lung lesion from mammary carcinoma in apicoposterior segment of upper lobe of left lung. Axial CT scans show crossing of major pulmonary fissure as risk factor for pneumothorax during radiofrequency ablation. Axial CT scans show pneumothorax (arrows) after traversal of oblique pulmonary fissure (arrowhead) with needle electrode.

 


Figure 6
View larger version (124K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C 52-year-old woman with metastatic lung lesion from mammary carcinoma in apicoposterior segment of upper lobe of left lung. Axial CT scans show crossing of major pulmonary fissure as risk factor for pneumothorax during radiofrequency ablation. Axial CT scans show pneumothorax (arrows) after traversal of oblique pulmonary fissure (arrowhead) with needle electrode.

 
Pneumothorax is a frequent problem that can complicate transthoracic radiofrequency ablation of lung neoplasms. In most large studies [1-12], the incidence range is 15-45%. The incidence of pneumothorax after radiofrequency ablation is similar to the incidence of pneumothorax after lung biopsy. Reports in the literature [16-19] show that both techniques are limited by chest wall and lung puncture and lesion invasiveness. Marked pneumothorax not only leads to postablation morbidity but also intimately affects the end results of ablation therapy owing to premature termination of the ablation session because either clinical compromise of the patient's condition necessitates immediate management of pneumothorax or adequate positioning of the electrode is not technically feasible, rendering the ablation session unsuccessful (in 28.6% of pneumothorax patients according to our results). Significant risk factors in our study were age older than 60 years, emphysema, lesions smaller than 1.5 cm, basal position of the pulmonary lesion, aerated lung in the ablation track traversed by electrode for a distance greater than 2.5 cm, and crossing of a major pulmonary fissure in the ablation track.

Emphysema is characterized pathologically by permanent enlargement of airspaces distal to the terminal bronchiole with destruction of alveolar walls [20]. Emphysema is usually classified in terms of the part of the acinus predominantly affected: proximal (centriacinar, more commonly termed centrilobular, emphysema), distal (paraseptal emphysema), or whole acinus (panacinar or, less commonly, panlobular emphysema). The CT appearance of emphysema consists of focal areas or regions of low attenuation, usually without visible walls [21]. In the case of panacinar emphysema, decreased attenuation is more diffuse. The effect of emphysema (Fig. 3) as one of the major individual risk factors for pneumothorax during ablation was described by Yamagami et al. [12]. The anatomic distribution of emphysema is the most important effect of the disease process on the risk of development of pneumothorax, especially when emphysematous bullae are traversed in the electrode track.

Small lesion size carries the risk of pneumothorax owing to excessive manipulation of the needle tip during targeting of the lesion. Central positioning of the electrode within the lesion is needed to overcome the high resistance to current flow if the electrode is not centrally located within the lesion. This manipulation results in tearing of lung parenchyma when the lesion is relatively small, and the patient is required to perform a breath-hold for a longer time to allow correct positioning of the needle inside the lesion. This finding has been made by many other authors [12, 17, 22-27]. Basal lesions (Fig. 4A, 4B, and 4C) are subject to the effect of the diaphragm, being more prominent on the basal lung zone than the upper lung zone and leading to a shearing effect of both the pleura and lung parenchyma.

Previous reports [15, 16, 18, 22-24] have shown that the greater is the depth of needle penetration from the pleural surface to the edge of the lesion, the higher is the rate of pneumothorax. Crossing a major pulmonary fissure in the ablation track is another risk factor that can be attributed to the crossing of many pleural surfaces in the track of the electrode (Fig. 4A, 4B, and 4C). One study [25] showed that the number of needle passes and the needle angulation were important to the occurrence of pneumothorax. Another study [26] showed no relation between the number of pleural passes and the rate of pneumothorax. Technical skill of the radiologist is extremely important because manipulations and the duration of the procedure are optimally reduced and, hence, can efficiently reduce the incidence of pneumothorax [27].

The results reported by Hiraki et al. [22], which included 224 ablation sessions in 142 patients, support our results regarding the significant effect of increased length of aerated lung traversed by the electrode and lesion location in the basal position of the lung. Their results and ours differed, however, in that they found sex a significant variable. They also found that a history of pulmonary surgery and ablation of an increased number of lesions per session had an effect on the increased incidence of pneumothorax. We eliminated the latter risk effect from our study because our protocol calls for ablation of one lesion per session.

Patients should be observed carefully after ablation for the development of delayed pneumothorax. After two sessions in this study, pneumothorax increased progressively within 24 hours after ablation, necessitating manual evacuation.

That our analysis did not include all sessions and that repeated sessions were considered independent sessions may be liable to criticism. Repeated sessions cannot be considered independent because multiple measurements in each patient are at least somewhat correlated. However, in only two cases did pneumothorax develop repeatedly at successive ablations. Another limitation of this study was that the analysis of risk factors included a relatively low incidence of pneumothorax (14 of 124 ablation sessions).

We conclude that pneumothorax complicating radiofrequency ablation of lung neoplasms is rather unpredictable but that many risk factors involved can lead to a higher incidence among some patients. We can classify these factors into technically avoidable risk factors and inevitable risk factors. Risk can be avoided by planning needle access for the shortest distance between the pleural surface and the lesion to minimize the distance of lung parenchyma traversed, by avoiding crossing a major pulmonary fissure in the track of the needle, and by avoiding multiple pleural punctures by multiple electrodes. Inevitable risk factors include age; the presence of chronic obstructive pulmonary disease; and the presence of deep, basal, and small lesions. Patients with inevitable risk factors are at high risk of pneumothorax.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR 2000; 174:57 -59[Free Full Text]
  2. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007;243 : 268-275[Abstract/Free Full Text]
  3. Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities—part I. J Vasc Interv Radiol 2001; 12:1021 -1032[Medline]
  4. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004;231 : 850-857[Abstract/Free Full Text]
  5. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer—a preliminary report of 33 patients. AJR 2004; 183:1003 -1011[Abstract/Free Full Text]
  6. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004;230 : 125-134[Abstract/Free Full Text]
  7. King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004;91 : 217-223[CrossRef][Medline]
  8. Steinke K, King J, Glenn DW, Morris DL. Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: tips from preliminary experience. AJR 2004;183 : 605-611[Free Full Text]
  9. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004;15 : 463-470[Medline]
  10. Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004;11 : 207-212[CrossRef][Medline]
  11. vanSonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions. Part 2. Initial clinical experience: technical and multidisciplinary considerations in 30 patients. AJR 2005; 184:381 -390[Abstract/Free Full Text]
  12. Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol2006; 17:1625 -1629[CrossRef][Medline]
  13. Steinke K. Radiofrequency ablation (RFA). In: Vogl TJ, Helmberger TK, Mack MG, Reiser MF, eds. Percutaneous tumor ablation in medical radiology. Berlin, Germany: Springer-Verlag, 2008:179 -196
  14. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006; 16:77 -84[CrossRef][Medline]
  15. Bradley J. Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol2007; 2[suppl 3]:S118 -S124[CrossRef][Medline]
  16. Westcott JL. Direct percutaneous needle aspiration of localized pulmonary lesions: result in 422 patients. Radiology1980; 137:31 -35[Abstract/Free Full Text]
  17. Li H, Boiselle PM, Shepard JO, Trotman-Dickenson B, McLoud TC. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. AJR 1996; 167:105 -109[Abstract/Free Full Text]
  18. Kazerooni EA, Lim FT, Mikhail A, Martinez FJ. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology 1996;198 : 371-375[Abstract/Free Full Text]
  19. Laurent F, Latrabe V, Vergier B, Michel P. Percutaneous CT-guided biopsy of the lung: comparison between aspiration and automated cutting needles using a coaxial technique. Cardiovasc Intervent Radiol 2000; 23:266 -272[CrossRef][Medline]
  20. [No authors listed]. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985;132 : 182-185[Medline]
  21. Foster WL Jr, Gimenez EI, Roubidoux MA, et al. The emphysemas: radiologic-pathologic correlations. RadioGraphics1993; 13:311 -328[Abstract]
  22. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology2006; 241:275 -283[Abstract/Free Full Text]
  23. Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology2003; 229:475 -481[Abstract/Free Full Text]
  24. Saji H, Nakamura H, Tsuchida T, et al. The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT guided lung biopsy: the angle of the needle trajectory is a novel predictor. Chest 2002; 121:1521 -1526[Abstract/Free Full Text]
  25. Cox JE, Chiles C, McManus CM, Aquino SL, Choplin RH. Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology 1999;212 : 165-168[Abstract/Free Full Text]
  26. Miller KS, Fish GB, Stanley JH, Schabel SI. Prediction of pneumothorax rate in percutaneous needle aspiration of the lung. Chest 1988; 93:742 -745[Abstract/Free Full Text]
  27. Yeow KM, Su IH, Pan KT, et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest 2004;126 : 748-754[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nour-Eldin, N.-E. A.
Right arrow Articles by Vogl, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nour-Eldin, N.-E. A.
Right arrow Articles by Vogl, T. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS